MMRGlobal Enters Into Agreement With Ararat International to Bring Personal Health Records to the Middle East

MMRGlobal Enters Into Agreement With Ararat International to Bring Personal 
Health Records to the Middle East 
LOS ANGELES, CA and DUBAI, UNITED ARAB EMIRATES -- (Marketwired) --
05/07/13 --  MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading
provider of Personal Health Records (PHRs) MyEsafeDepositBox storage
solutions and MMRPro document management and imaging systems for
healthcare professionals, today announced that it has entered into an
agreement with Dubai-based Ararat International(TM) Trading, LLC, a
leading distributor of consumer, defense, agricultural, and
transportation products, to represent MMR in the Middle East. Ararat
International will identify licensees and strategic partners to sell
and localize the Company's patented Personal Health Records and other
eHealth products and services in the region. Ararat International was
established in Sudan, Africa in 1974 representing clients that
include and have included Michelin, Peugeot, Dassault Aviation, Caffe
Musetti of Italy, Komatsu, Aerospatiale, Alcatel-Lucent and Alstom,
one of the largest publicly traded power and rail companies in the
world, amongst numerous others. Ararat has offices in UAE, Sudan, Las
Vegas and Los Angeles. 
In April 2011, MMRGlobal CEO Robert H. Lorsch met with His Highness
Sheikh Hamad Bin Khalifa Al-Thani, the Emir of Qatar, to discuss
offering its products and services in Qatar's Science & Technology
Park, where a Middle Eastern PHR platform to cover the region could
also be hosted. The Company has continued to make inroads in Qatar
through these contacts and others in Australia. In support of this
and the Company's many other efforts, Ararat International has
numerous representatives throughout the Middle East, including
Turkey, Kuwait, Saudi Arabia, Qatar, United Arab Emirates and the
Kingdom of Bahrain. Because the Middle East is known to have one of
the highest concentrations of expats in the world, billions of
dollars are being spent to build Personal Health Record systems so
that travelers and the expat community have their medical records
wherever they are in an emergency.  
According to Lorsch, "We have been working on identifying
representation in the Middle East since 2011 when we were introduced
to the Emir of Qatar. It is our plan to work with Ararat
International to identify specialists in the region who can partner
and support us. Since the beginning of last year, there has been an
aggressive movement in the region to create eHealth products and
services with particular emphasis on PHRs. Numerous multinational
organizations and at least one government have asked us to consider
participating in the region as a strategic partner in eHealth
programs. However, regional protocols require that we need support in
doing business in the region which is where Ararat International
comes in. If we are investing in the market, we want to succeed in
the market, and this is one way to help ensure our success."  
Garo S. Vanian, President of Ararat International, who was awarded
the French Legion of Honor in 1993 for the development of
Franco-African Business Relations, said, "We look forward to
representing MMRGlobal's health IT products and services in Ararat
International's territories in the Middle East. This is a great
opportunity because it enables businesses and organizations in this
region to quickly implement the newest technologies in eHealth. By
offering MyMedicalRecords, we can take advantage of trends and
successes in the U.S. and apply it to the healthcare industry in the
Middle East. We look forward to starting presentations with our
largest business clients as soon as next week when our Los Angeles
team is in Dubai."  
About Ararat International
 Ararat International(TM) and Ararat,
Inc., incorporated in Nevada, operating through its wholly-owned
foreign subsidiary, Ararat International Trading LLC, is a limited
liability company incorporated in Dubai, United Arab Emirates. The
company was established in 1974 as sole distributors of consumer,
defense, agricultural, and transportation products for the Middle
Eastern and African Economies.  Family-owned and operated, Ararat
International is referred to by the Sunday Times(TM) UK AS "the
Harrods(TM) of Khartoum" due to the big affiliations (or big brands)
Ararat represents.  To learn more about Ararat, Inc. go to
www.araratinc.com. 
About MMRGlobal
 MMRGlobal, Inc., through its wholly-owned operating
subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use
online Personal Health Records ("PHRs") and electronic safe deposit
box storage solutions, serving consumers, healthcare professionals,
employers, insurance companies, financial institutions, retail
pharmacies, and professional organizations and affinity groups. The
MyMedicalRecords PHR enables individuals and families to access their
medical records and other important documents, such as birth
certificates, passports, insurance policies and wills, anytime from
anywhere using the Internet. MyMedicalRecords is built on
proprietary, patented technologies to allow documents, images and
voicemail messages to be transmitted and stored in the system using a
variety of methods, including fax, phone, or file upload without
relying on any specific electronic medical record platform to
populate a user's account. The Company's professional offering,
MMRPro, is designed to give physicians' offices an easy and
cost-effective solution to digitizing paper-based medical records and
sharing them with patients through an integrated patient portal.
Through its merger with Favrille, Inc. in January 2009, the Company
acquired intellectual property biotech assets that include anti-CD20
antibodies and data and samples from its FavId(TM)/Specifid(TM)
vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's
lymphoma. To learn more about MMRGlobal, Inc. visit
www.mmrglobal.com. View demos and video tutorials of the Company's
products and services at www.mmrtheater.com. 
Forward-Looking Statements 
 All statements in this press release
that are not strictly historical in nature, including, without
limitation, the Company's future performance, management's
expectations, beliefs, intentions, estimates or projections,
constitute "forward-looking statements." Such forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the Company's actual results to be materially
different from historical results or from any results expressed or
implied by such forward-looking statements. Some can be identified by
the use of words (and their derivations) such as "need,"
"possibility," "potential," "intend," "offer," "development," "if,"
"negotiate," "when," "begun," "believe," "achieve," "will,"
"estimate," "expect," "maintain," "plan," and "continue," or the
negative of these words. Actual outcomes and results of operations
and the timing of selected events may differ materially from the
results predicted, and any reported results should not be considered
as an indication of future performance. Such statements are
necessarily based on assumptions and estimates and are subject to
various risks and uncertainties, including those relating to the
possible invalidity of the underlying assumptions and estimates and
possible changes or developments in economic, business, industry,
market, legal and regulatory circumstances and conditions and actions
taken or omitted to be taken by third parties, including customers,
suppliers, business partners, agents, potential licensees,
competitors and legislative, judicial and other governmental
authorities and officials. Factors that could cause or contribute to
such differences include, but are not limited to: unexpected outcomes
with respect to intellectual property enforcement actions, claims of
intellectual property infringement and general intellectual property
litigation; our ability to maintain, develop, monetize and protect
our patent portfolio for both the Company's health IT and
biotechnology intellectual property assets in the U.S. and
internationally; the timing of milestone payments in connection with
licensing our intellectual property; our ability to establish and
maintain strategic relationships; changes in our relationships with
our licensees; the risk the Company's products are not adopted or
viewed favorably by the healthcare community and consumer retail
market; business prospects, results of operations or financial
condition; risks related to the current uncertainty and instability
in financial and lending markets, including global economic
uncertainties; the timing and volume of sales and installations; the
length of sales cycles and the installation process; the market's
acceptance of new product and service introductions; competitive
product offerings and promotions; changes in government laws and
regulations and future changes in tax legislation and initiatives in
the healthcare industry both in the U.S. and internationally;
undetected errors in our products; the possibility of interruption at
our data centers; risks related to third party vendors; risks related
to obtaining and integrating third-party licensed technology; risks
related to a security breach by third parties; risks associated with
recruitment and retention of key personnel; other litigation matters;
uncertainties associated with doing business internationally across
borders and territories; and additional risks discussed in the
Company's filings with the Securities and Exchange Commission. The
Company is providing this information as of the date of this release
and, except as required by applicable law, does not undertake any
obligation to update any forward-looking statements contained in this
release as a result of new information, future events or otherwise.   
CONTACT: 
Michael Selsman
Public Communications Co.
ms@publiccommunications.biz
(310) 922-7033